AIPATCH NUMBING PAIN RELIEF

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
AIPATCH NUMBING PAIN RELIEF
Generic name
LIDOCAINE
Manufacturer
Active Intelligence, LLC
Product type
HUMAN OTC DRUG
SPL set ID
56f27540-9b2a-4266-9e15-a5b2d738c7a1
SPL ID
5c3c5927-e40b-045b-e063-6294a90ac895
Version
2
Effective date
2026-09-24
Source export date
2026-11-13
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/2aa9706206c534e56285cf80077b2cca2320f0a236e2aa30e80d064749f7c888/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:02:29
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings for external use only When using this product • use only as directed. Read and follow all directions and warnings on this carton • do not bandage tightly • avoid contact with eyes and mucous membranes • do not use at the same time as other topical analgesics • do not remove when wet or directly after shower, allow to dry and then slowly remove Stop use and ask a doctor if • condition worsens • symptoms persist for more than 7 days or clear up and occur again within a few days • you experience signs of skin injury, such as pain, swelling or blistering where the patch was applied • If pregnant or breast-feeding, ask a health professional before use • If swallowed, get medical help or contact a Poison Control Center right away

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.